| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT07540988 FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing… |
Trial sites expanded: 100 -> 126 locations |
| 2026-06-03 | NCT07540988 FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing… |
Trial sites expanded: 52 -> 100 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07570888 | This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate… | Pulmonary Fibrosis | Not Yet Recruiting |
| Phase 3 | |||
| NCT07201922 | A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People… | Familial Pulmonary Fibrosis | Recruiting |
| NCT06806592 | A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic… | Interstitial Lung Diseases | Recruiting |
| NCT06238622 | A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary… | Idiopathic Pulmonary Fibrosis | Recruiting |
| NCT07366034 | A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps… | Fibrosing Interstitial Lung Disease | Not Yet Recruiting |
| NCT07540988 | FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing… | Interstitial Lung Diseases | Not Yet Recruiting |
| Phase 2 | |||
| NCT06195072 | Platform Clinical Study for Conquering Scleroderma | Interstitial Lung Disease Due to Systemic Disease | Recruiting |
| NCT06241560 | A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone… | Idiopathic Pulmonary Fibrosis | Recruiting |